Hologic Earnings miss, Revenue Inline In Q2 By Investing.com

Hologic reported on Wednesday second quarter earnings that missed analysts’ forecasts and revenue that was inline with expectations.

Hologic announced earnings per share of $2.59 on revenue of $1.54B. Analysts polled by Investing.com anticipated EPS of $2.61 on revenue of $1.54B.

Hologic shares are down 10% from the beginning of the year and are trading at $63.00 , down-from-52-week-high.They are under-performing the S&P 500 which is up 11.41% from the start of the year.

Hologic shares lost 13.00% in after-hours trade the report.

Hologic follows other major Healthcare sector earnings this month

Hologic’s report follows an earnings beat by J&J on April 20, who reported EPS of $2.59 on revenue of $22.32B, compared to forecasts EPS of $2.34 on revenue of $21.98B.

Abbott Labs had beat expectations on April 20 with first quarter EPS of $1.32 on revenue of $10.46B, compared to forecast for EPS of $1.27 on revenue of $10.69B.

Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com’s earnings calendar